| Life expectancy | [138] | Correlational: Longitudinal (25 years) | M + W | Lower annual death rate | PVI frequency: + (M) Enjoyment of PVI: + (W) |
| [139] | Correlational: Longitudinal (10 years) | M | Lower annual death rate | PVI frequency: + |
| [140] | Correlational: International ecological | M + W | Life expectancy (national) | PVI frequency: + |
| [143] | Experimental | Crickets (female) | Life expectancy | PVI frequency: + |
| [144] | Mixed correlational and experimental (deprenyl trial) | Rats (male) | Life expectancy | PVI frequency: + |
| Vaginal function | [60] | Review | W | Vaginal tone, oxygenation, blood flow | PVI: + Condoms: − (oxygenation, blood flow effects?) |
| Less functional musculoskeletal disturbance | [61] | Correlational | W | Anatomically normal gait | Vaginal orgasm history: + Clitoral orgasm history: 0 |
| Less body fatness | [62] | Correlational | M + W | Slimmer waist and/or hip circumference | PVI frequency: + Masturbation frequency: − Noncoital sex frequency: 0/+ |
| [63] | Correlational | Rats (Male) | Nonobese vs. obese | PVI frequency: + Cunnilingus: 0 |
| Nutritional enhancement effects | [69] | Experimental (RCT) | M + W | Effect of 14 days 3,000 mg/day ascorbic acid vs. placebo | PVI frequency: + (effect attributable to W) Masturbation frequency: 0 Noncoital sex frequency: 0 |
| Better heart rate variability | [71] | Correlational | M + W | Heart rate variability (resting) | PVI frequency: + Masturbation frequency: 0 Noncoital sex frequency: 0 Subjective importance of PVI: + |
| [70] | Correlational | M + W | Heart rate variability (resting) | PVI frequency: + Masturbation frequency: 0 Noncoital sex frequency: 0 Subjective importance of PVI: + |
| Lower resting blood pressure | [71] | Correlational | M + W | Lower diastolic blood pressure (resting) | PVI frequency: + Masturbation frequency: 0 Noncoital sex frequency: 0 Note: ns results for diastolic blood pressure in [70] |
| [72] | Correlational | M | Less likelihood of hypertension (newly diagnosed and untreated) | PVI frequency: + |
| Less blood pressure reactivity to acute stress | [73] | Mixed (correlational with sexual behavior, experimental stressor) | M + W | Less blood pressure increase before and during stress, and faster recovery after stress | PVI (past 2 weeks): + Masturbation (frequency past 2 weeks): 0/− Pattern: PVI only > PVI + days with only other sexual activities ≥ only other sexual activities |
| Better exercise value | [74] | Experimental | M | Better oxygen uptake, and blood pressure and heart rate stimulation | PVI > masturbation |
| Less pre-eclampsia risk (3 studies) | [75−77] | Correlational | W | Less pre-eclampsia risk | Condoms: − PVI frequency: + Fellatio: + |
| Improved testosterone levels | [78] | Experimental/Clinical | M | Restoration of normal testosterone level with various nonhormonal treatments of erectile dysfunction | PVI frequency: + |
| Decreased menopausal hot flashes | [81] | Experimental (randomized nonblind trial of coitus vs. no coitus) | W | Effect on menopausal hot flashes and LH and FSH normalization | PVI: + |
| Less intense cortisol response to stress | [82] | Mixed (correlational with sexual behavior, experimental stressor) | M + W | Less intense cortisol response to stressor | Earlier age at first PVI: + (W, ns trend for M) |
| Increases in dopamine levels in the nucleus accumbens | [83] | Experimental | Rats (Female) | Increases in dopamine levels in the nucleus accumbens | PVI: + Mounting/cuddling/external stimulation without PVI: 0 |
| Greater prolactin increase following orgasm | [86] | Experimental | M + W | Greater prolactin increase following orgasm | PVI >> masturbation |
| Better sperm quality | [89] | Experimental | M | Volume of seminal plasma, sperm count, sperm motility, and percentage of morphologically healthy sperm | PVI > masturbation |
| [91] | Experimental | M | Greater sperm volume and quality | PVI > masturbation |
| Better prostatic secretory function | [89] | Experimental | M | Better prostatic secretory function | PVI > masturbation |
| Lower prostate specific antigen levels and fewer prostate abnormalities | [88] | Correlational | M (with erectile dysfunction) | Lower prostate specific antigen levels and fewer prostate abnormalities | Masturbation: − |
| Better elimination of waste products | [90] | Experimental | M | Increased concentrations and total amounts of prostaglandin E and polyamines (putrescine, spermidine and spermine) | PVI > masturbation |
| Less prostate cancer risk | [95] | Correlational | M | Less prostate cancer risk | PVI frequency: 0 Masturbation frequency: ? |
| [96] | Correlational | M | Less prostate cancer risk | PVI frequency: + Masturbation frequency: − Prostitute use: − |
| [97] | Correlational | M | Less prostate cancer risk | PVI frequency: + Homosexual partners: − Prostitute use: − |
| Less breast cancer risk | [98] | Correlational | W | Less breast cancer risk | PVI frequency: + Condoms: − Coitus interruptus: − |
| [99,100] | Correlational | W | Less breast cancer risk | PVI frequency: + Condoms: − Coitus interruptus: − |
| [101] | Correlational | W | Less breast cancer risk | Lifetime number of sexual partners: + |
| Tissue could not become infected by exposure to HIV (3 studies) | [132–134] | Experimental (tissue challenge without excess damage to the tissue) | W (biopsies) | Tissue could not become infected by exposure to large quantities of HIV | Vaginal: + Cervical: + Rectal: − Note: See the relevant section for important extensive references to other studies with similar implications |
| Less impairment of immune function | [135] | Correlational | W + MTF Transsexuals | Delayed-type hypersensitivity (DTH) and CD4/CD8 ratios | Receptive anal intercourse: − |
| [136] | Experimental | Rabbits (Male) | Less immune complexes, sperm antibodies, and antibodies to peripheral blood lymphocyte antigens; additional immune effects including impaired humoral immune response to T lymphocyte-dependent antigens, keyhole limpet hemocyanin, and sheep red blood cells | Rectal insemination (vs. saline introduced into the rectum): − |
| Immune benefits including possible resistance to HIV-1 infection | [137] | Correlational | M + W | resistance to HIV-1 infection by challenging activated CD4-positive T cells with CCR5-binding and CXCR4-binding HIV-1 strains | PVI: + Condoms for PVI: − |